Physician profile

John C Lin

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Fresno, CA

NPI 1992961270

$35,610.06

in general payments reported to CMS, 2019-2025

33 companies · $6,880 in 2025

The $6,880 reported for 2025 was more than what 86% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$11,650.00
Food and Beverage$5,544.87
Travel and Lodging$2,445.76
Education$39.12

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $17,663.27 2019-2025 Da Vinci Sp, Da Vinci Surgical System
Angiodynamics, INC. $5,617.05 2022-2025 Angiovac, Alphavac
Edwards Lifesciences Corporation $1,789.02 2021-2025
Abbott Laboratories $1,605.52 2019-2025 2nd Gen Centrimag Primary Console, Epic, Sjm Regent
Atricure, INC. $1,585.80 2019-2025 Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System
W. L. Gore & Associates, INC. $1,514.69 2025 Gore Tag Conformable Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis
Olympus Corporation of The Americas $1,443.34 2022
Abiomed $1,135.18 2019-2025 Impella
Zimmer Biomet Holdings, INC. $999.07 2021-2023 Advantagerib, Sternalock Blu System
Bolton Medical INC $234.44 2021-2022
Baxter Healthcare $187.84 2022-2024 Floseal, Coseal, Preveleak
Inari Medical, INC. $185.37 2021-2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Medtronic Vascular, INC. $171.69 2019-2020
Medtronic, INC. $169.93 2024 Penditure
Lsi Solutions INC $164.32 2021
Show all 33 companies
CompanyGeneral paymentsYearsTop products
Polynovo North America LLC $154.53 2023
Astrazeneca Pharmaceuticals Lp $154.50 2022-2024 Tagrisso
Integra Lifesciences Corporation $147.68 2022
Siemens Medical Solutions USA, INC. $118.35 2023 Cios Spin
Veran Medical Technologies, INC. $108.92 2020
Werfen USA LLC $90.86 2022
Becton, Dickinson and Company $74.69 2024-2025 Progel Applicator Spray Tips
Davol INC. $58.91 2025 Progel Applicator Spray Tips
Stryker Corporation $49.14 2022-2023 Na, Vsp System, Vsp Cranial
Octapharma USA, INC. $34.37 2019
Merck Sharp & Dohme LLC $29.94 2025 Keytruda
Kls-Martin L.P. $23.14 2019
Smith+Nephew, INC. $22.38 2025 Collagenase Santyl
Cornerstone Medical Associates, INC. $19.59 2024
Abbvie INC. $15.99 2025
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $15.71 2023 Lifevest
Ethicon US, LLC $14.01 2022
Conmed Corporation $10.82 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

John C Lin

$35,610.06

in general payments reported 2019-2025

Years
2019-2025
Top company
Intuitive Surgical, INC.
Context
The $6,880 reported for 2025 was more than what 86% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).

https://glasscript.com/doctor/648091/john-c-lin

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.